What is Encompass Health Corp's earnings per share (EPS)?

Encompass Health Corp (EHC) reported diluted earnings per share of $5.54 for fiscal year 2025. This represents a 24.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Encompass Health Corp Financials

EHC

FY2025 annual

Revenue $5.9B +10.5% YoY

Net Income $566.2M +24.2% YoY

EPS (Diluted) $5.54 +24.2% YoY

Free Cash Flow $439.2M +21.9% YoY

Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Encompass Health Corp (EHC) reported $5.9B in revenue for fiscal year 2025, up 10.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EHC FY2025 2026-05-01

Encompass Health is turning steady revenue growth into higher profit and cash while steadily delevering the balance sheet.

From FY2023 to FY2025, operating cash flow climbed from $851M to $1.18B, a faster improvement than reported earnings alone would suggest. At the same time, debt to equity fell materially while capex reached $736M, which means more of the asset base is being funded internally rather than by adding leverage.

FY2025 operating cash flow of $1.18B was more than double net income of $566M, so profit is translating into cash rather than remaining mostly an accounting result. But free cash flow was only $439M, showing this is still a capital-intensive model where reinvestment absorbs much of the cash before it becomes discretionary.

The balance sheet looks stronger in solvency than in day-to-day liquidity: liabilities stayed relatively contained as equity and retained earnings built, so financial flexibility improved without needing a larger debt load. Still, cash on hand was only $72M against current liabilities of $836M, which suggests short-term liquidity depends more on steady collections and operating inflow than on a large cash cushion.

Financial Health Signals

Financial Health Score 32/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Encompass Health Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Not available for Encompass Health Corp, and counted as zero in the overall score.

Growth

Encompass Health Corp's revenue grew 10.5% year-over-year to $5.9B, a solid pace of expansion. This earns a growth score of 68/100.

Leverage

Encompass Health Corp has a moderate D/E ratio of 1.00. This balance of debt and equity financing earns a leverage score of 46/100.

Liquidity

Encompass Health Corp's current ratio of 1.08 is below the typical benchmark, resulting in a score of 23/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Encompass Health Corp has a free cash flow margin of 7.4%, earning a moderate score of 56/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Not available for Encompass Health Corp, and counted as zero in the overall score.

Piotroski F-Score Partial

8/8

Encompass Health Corp passes 8 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

2.08x

For every $1 of reported earnings, Encompass Health Corp generates $2.08 in operating cash flow ($1.2B OCF vs $566.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$5.9B

YoY+10.5%

5Y CAGR+10.7%

Encompass Health Corp generated $5.9B in revenue in fiscal year 2025. This represents an increase of 10.5% from the prior year.

Net Income

$566.2M

YoY+24.2%

5Y CAGR+14.8%

10Y CAGR+12.0%

Encompass Health Corp reported $566.2M in net income in fiscal year 2025. This represents an increase of 24.2% from the prior year.

EPS (Diluted)

$5.54

YoY+24.2%

5Y CAGR+14.2%

10Y CAGR+11.2%

Encompass Health Corp earned $5.54 per diluted share (EPS) in fiscal year 2025. This represents an increase of 24.2% from the prior year.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

$439.2M

YoY+21.9%

5Y CAGR+7.1%

10Y CAGR+1.6%

Encompass Health Corp generated $439.2M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 21.9% from the prior year.

Cash & Debt

$72.2M

YoY-15.5%

5Y CAGR-17.2%

10Y CAGR+1.6%

Encompass Health Corp held $72.2M in cash against $2.4B in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.72

YoY+12.5%

5Y CAGR-8.5%

10Y CAGR-2.0%

Encompass Health Corp paid $0.72 per share in dividends in fiscal year 2025. This represents an increase of 12.5% from the prior year.

Shares Outstanding

99M

YoY-1.3%

5Y CAGR0.0%

Encompass Health Corp had 99M shares outstanding in fiscal year 2025. This represents a decrease of 1.3% from the prior year.

Margins & Returns

Net Margin

9.5%

YoY+1.1pp

5Y CAGR+1.6pp

Encompass Health Corp's net profit margin was 9.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.1 percentage points from the prior year.

Return on Equity

23.2%

YoY+1.2pp

5Y CAGR+5.3pp

10Y CAGR-6.7pp

Encompass Health Corp's ROE was 23.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.2 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Capital Allocation

Share Buybacks

$158.0M

YoY+408.0%

5Y CAGR+91.7%

10Y CAGR+13.3%

Encompass Health Corp spent $158.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 408.0% from the prior year.

Capital Expenditures

$736.4M

YoY+14.6%

5Y CAGR+13.4%

10Y CAGR+19.1%

Encompass Health Corp invested $736.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 14.6% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

EHC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EHC annual income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$6.2B	$5.9B+10.5%	$5.4B+11.9%	$4.8B+10.4%	$4.3B+8.3%	$4.0B+12.6%	$3.6B-22.6%	$4.6B+7.7%	$4.3B+9.3%	$3.9B+7.4%	$3.6B	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$245.3M	$236.2M+12.9%	$209.2M+3.7%	$201.7M+30.7%	$154.3M-9.0%	$169.5M+11.8%	$151.6M-38.6%	$247.0M+12.2%	$220.2M+28.2%	$171.7M+28.7%	$133.4M+0.1%	$133.3M+6.8%	$124.8M+4.8%	$119.1M+1.0%	$117.9M+6.7%	$110.5M
Operating Income	N/A	N/A	N/A	N/A	$539.5M-3.6%	$559.6M-0.8%	$563.9M-7.9%	$612.1M+10.2%	$555.2M-4.0%	$578.3M-1.7%	$588.1M+21.1%	$485.7M	N/A	N/A	N/A	N/A
Interest Expense	$125.6M	$123.2M-10.3%	$137.4M-4.3%	$143.5M-18.3%	$175.7M+6.9%	$164.3M-10.6%	$183.7M+15.0%	$159.7M+8.4%	$147.3M-4.6%	$154.4M-10.3%	$172.1M+20.4%	$142.9M+30.9%	$109.2M+8.8%	$100.4M+6.7%	$94.1M-21.2%	$119.4M
Income Tax	$210.3M	$192.9M+28.4%	$150.2M+13.6%	$132.2M+32.1%	$100.1M-1.8%	$101.9M+36.4%	$74.7M-35.5%	$115.9M-2.5%	$118.9M-18.4%	$145.8M-11.0%	$163.9M+15.5%	$141.9M+28.2%	$110.7M+771.7%	$12.7M-88.3%	$108.6M+192.7%	$37.1M
Net Income	$621.0M	$566.2M+24.2%	$455.7M+29.5%	$352.0M+29.9%	$271.0M-34.3%	$412.2M+45.0%	$284.2M-20.8%	$358.7M+22.7%	$292.3M+7.8%	$271.1M+9.5%	$247.6M+35.2%	$183.1M-17.5%	$222.0M-31.4%	$323.6M+74.9%	$185.0M-11.4%	$208.7M
EPS (Diluted)	—	$5.54+24.2%	$4.46+28.5%	$3.47+28.5%	$2.70-34.3%	$4.11+44.2%	$2.85-21.1%	$3.61+23.2%	$2.93+3.2%	$2.84+9.7%	$2.59+35.6%	$1.91-16.6%	$2.29-11.2%	$2.58+54.5%	$1.67-14.8%	$1.96

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$1.6B+0.7%	$1.6B+2.7%	$1.5B+4.5%	$1.5B+1.4%	$1.5B+0.2%	$1.5B+3.6%	$1.4B+4.0%	$1.4B
SG&A Expenses	$62.6M+7.6%	$58.2M-14.9%	$68.4M+21.9%	$56.1M-5.6%	$59.4M+13.6%	$52.3M-4.0%	$54.5M+0.9%	$54.0M
Interest Expense	$32.8M+3.1%	$31.8M+5.3%	$30.2M-1.9%	$30.8M+1.3%	$30.4M-4.4%	$31.8M-3.6%	$33.0M-5.4%	$34.9M
Income Tax	$53.6M-5.0%	$56.4M+1.8%	$55.4M+23.4%	$44.9M-12.0%	$51.0M+22.6%	$41.6M+10.6%	$37.6M+4.4%	$36.0M
Net Income	$153.9M-20.9%	$194.5M+33.1%	$146.1M+15.5%	$126.5M-11.0%	$142.1M-6.2%	$151.5M+25.3%	$120.9M+11.7%	$108.2M
EPS (Diluted)	$1.54-20.2%	$1.93	N/A	$1.24-10.8%	$1.39-6.1%	$1.48	N/A	$1.06

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

EHC Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EHC annual balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$7.1B+8.5%	$6.5B+7.1%	$6.1B+8.3%	$5.6B-17.9%	$6.9B+6.5%	$6.4B+6.0%	$6.1B+17.5%	$5.2B+6.4%	$4.9B+3.9%	$4.7B+1.6%	$4.6B+35.9%	$3.4B+33.7%	$2.5B+4.5%	$2.4B+6.7%	$2.3B
Current Assets	$905.9M+2.1%	$886.9M+5.4%	$841.8M+17.4%	$717.2M-22.2%	$921.4M-2.9%	$948.6M+25.5%	$755.8M+14.2%	$662.1M-5.7%	$702.2M+7.3%	$654.5M+9.3%	$598.7M-12.8%	$686.6M+18.3%	$580.4M-8.9%	$636.8M+29.5%	$491.6M
Cash & Equivalents	$72.2M-15.5%	$85.4M+23.6%	$69.1M+217.0%	$21.8M-55.9%	$49.4M-73.4%	$185.6M+209.3%	$60.0M-13.3%	$69.2M+27.2%	$54.4M+34.3%	$40.5M-34.3%	$61.6M-7.6%	$66.7M+3.4%	$64.5M-51.4%	$132.8M+341.2%	$30.1M
Accounts Receivable	$613.4M+3.4%	$593.0M-1.1%	$599.8M+14.3%	$524.8M+4.5%	$502.1M-10.8%	$563.0M+12.9%	$498.7M+8.4%	$459.9M+0.1%	$459.5M+6.4%	$432.0M+7.1%	$403.3M+24.8%	$323.2M+23.5%	$261.8M+5.0%	$249.3M+11.9%	$222.8M
Goodwill	$1.3B+2.6%	$1.3B+0.2%	$1.3B+1.4%	$1.3B+2.1%	$1.2B+0.7%	$1.2B+0.8%	$1.2B-42.0%	$2.1B+6.5%	$2.0B+2.4%	$1.9B+2.0%	$1.9B+74.4%	$1.1B+137.3%	$456.9M+4.5%	$437.3M+3.7%	$421.7M
Total Liabilities	$3.8B+3.5%	$3.7B-3.1%	$3.8B+0.8%	$3.8B-15.5%	$4.5B+0.5%	$4.4B+7.1%	$4.1B+23.6%	$3.4B+3.3%	$3.2B-10.1%	$3.6B-2.5%	$3.7B+43.0%	$2.6B+32.3%	$2.0B+17.2%	$1.7B-22.4%	$2.2B
Current Liabilities	$836.4M-0.5%	$841.0M+28.1%	$656.4M+14.0%	$575.9M-23.1%	$748.8M+4.4%	$717.3M-0.5%	$721.0M+7.2%	$672.5M+30.0%	$517.5M+8.8%	$475.6M+11.5%	$426.4M+17.0%	$364.3M+16.9%	$311.6M+3.6%	$300.9M-3.9%	$313.2M
Long-Term Debt	$2.4B+3.7%	$2.4B-12.2%	$2.7B-2.0%	$2.7B-15.4%	$3.2B-0.3%	$3.3B+7.5%	$3.0B+22.0%	$2.5B-2.6%	$2.5B-14.6%	$3.0B-5.0%	$3.1B+50.0%	$2.1B+38.9%	$1.5B+21.4%	$1.2B+0.3%	$1.2B
Total Equity	$2.4B+18.0%	$2.1B+25.5%	$1.6B+25.7%	$1.3B-31.4%	$1.9B+20.4%	$1.6B+17.4%	$1.4B+5.9%	$1.3B+10.8%	$1.2B+56.6%	$735.9M+20.4%	$611.4M+29.2%	$473.2M+37.3%	$344.6M+18.4%	$291.0M+148.7%	$117.0M
Retained Earnings	$1.3B+61.8%	$796.7M+96.0%	$406.5M+251.3%	$115.7M-18.4%	$141.8M+158.5%	-$242.3M+54.0%	-$526.5M+40.5%	-$885.2M+24.7%	-$1.2B+18.8%	-$1.4B+14.6%	-$1.7B+9.7%	-$1.9B+10.6%	-$2.1B+13.3%	-$2.4B+7.1%	-$2.6B

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$7.5B+2.0%	$7.3B+3.2%	$7.1B+3.3%	$6.9B+1.2%	$6.8B+2.2%	$6.6B+1.6%	$6.5B+1.2%	$6.5B
Current Assets	$1.0B+1.2%	$1.0B+13.6%	$905.9M+4.2%	$869.8M-5.3%	$918.1M+0.8%	$910.9M+2.7%	$886.9M-5.0%	$933.9M
Cash & Equivalents	$107.7M-2.5%	$110.5M+53.0%	$72.2M+48.3%	$48.7M-50.9%	$99.1M+3.4%	$95.8M+12.2%	$85.4M-42.2%	$147.8M
Accounts Receivable	N/A	N/A	$613.4M	N/A	N/A	N/A	$593.0M	N/A
Goodwill	$1.3B+0.4%	$1.3B0.0%	$1.3B+1.1%	$1.3B0.0%	$1.3B+1.5%	$1.3B0.0%	$1.3B0.0%	$1.3B
Total Liabilities	$4.0B+1.3%	$3.9B+3.5%	$3.8B+3.7%	$3.7B-0.5%	$3.7B-0.2%	$3.7B+0.5%	$3.7B-1.3%	$3.7B
Current Liabilities	$873.4M-0.4%	$876.8M+4.8%	$836.4M+9.8%	$762.0M-11.9%	$865.1M+1.1%	$856.0M+1.8%	$841.0M-6.3%	$897.4M
Long-Term Debt	$2.6B+2.7%	$2.5B+3.4%	$2.4B+2.2%	$2.4B+3.2%	$2.3B-0.6%	$2.3B-1.1%	$2.4B+0.6%	$2.3B
Total Equity	$2.6B+3.0%	$2.5B+3.4%	$2.4B+2.7%	$2.4B+4.1%	$2.3B+5.6%	$2.2B+4.5%	$2.1B+5.5%	$2.0B
Retained Earnings	N/A	N/A	$1.3B	N/A	N/A	N/A	$796.7M	N/A

Not reported in any period shown, so not listed: Inventory.

EHC Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EHC annual cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$1.2B	$1.2B+17.2%	$1.0B+17.9%	$850.8M+20.5%	$705.8M-1.4%	$715.8M+1.6%	$704.7M+10.9%	$635.3M-16.7%	$762.4M+15.8%	$658.3M+2.8%	$640.2M+27.5%	$502.0M+10.4%	$454.6M-3.3%	$470.3M+14.3%	$411.5M+20.1%	$342.7M
Capital Expenditures	$799.1M	$736.4M+14.6%	$642.5M+10.2%	$583.1M+3.2%	$564.8M+7.7%	$524.6M+33.6%	$392.8M+5.5%	$372.4M+46.3%	$254.5M+12.7%	$225.8M+27.1%	$177.7M+38.4%	$128.4M-24.9%	$170.9M-12.4%	$195.2M+38.6%	$140.8M+40.4%	$100.3M
Free Cash Flow	$413.4M	$439.2M+21.9%	$360.3M+34.6%	$267.7M+89.9%	$141.0M-26.3%	$191.2M-38.7%	$311.9M+18.6%	$262.9M-48.2%	$507.9M+17.4%	$432.5M-6.5%	$462.5M+23.8%	$373.6M+31.7%	$283.7M+3.1%	$275.1M+1.6%	$270.7M+11.7%	$242.4M
Investing Cash Flow	-$826.4M	-$764.6M-17.0%	-$653.3M-8.4%	-$602.8M+3.9%	-$627.0M+5.9%	-$666.3M-63.5%	-$407.5M+38.0%	-$657.4M-54.9%	-$424.5M-50.0%	-$283.0M-23.1%	-$229.9M+79.7%	-$1.1B-28.8%	-$876.9M-287.7%	-$226.2M-26.5%	-$178.8M-626.8%	-$24.6M
Financing Cash Flow	-$390.0M	-$431.2M-30.4%	-$330.6M-67.6%	-$197.2M-35.3%	-$145.7M+39.3%	-$240.1M-64.6%	-$145.9M-402.7%	$48.2M+115.0%	-$321.2M+10.8%	-$359.9M+13.6%	-$416.4M-166.9%	$622.7M+46.7%	$424.5M+235.9%	-$312.4M-140.3%	-$130.0M+61.3%	-$336.3M
Dividends Paid	$75.2M	$71.1M+13.2%	$62.8M+4.0%	$60.4M-39.0%	$99.0M-11.8%	$112.2M+0.4%	$111.8M+2.9%	$108.7M+7.8%	$100.8M+10.2%	$91.5M+9.2%	$83.8M+8.5%	$77.2M+17.3%	$65.8M+319.1%	$15.7M	$0	$0
Share Buybacks	$247.0M	$158.0M+408.0%	$31.1M	$0	$0	$0-100.0%	$6.1M-86.7%	$45.9M	$0-100.0%	$38.1M-41.9%	$65.6M+44.8%	$45.3M+5.1%	$43.1M-81.6%	$234.1M	$0	$0

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$282.6M-9.7%	$313.1M-9.5%	$346.0M+27.8%	$270.8M+0.2%	$270.2M-6.4%	$288.6M+3.5%	$278.8M+4.1%	$267.8M
Capital Expenditures	$220.3M+35.7%	$162.4M-29.2%	$229.3M+22.6%	$187.1M+19.2%	$156.9M-3.8%	$163.1M-17.9%	$198.7M+34.7%	$147.5M
Free Cash Flow	$62.3M-58.7%	$150.7M+29.1%	$116.7M+39.4%	$83.7M-26.1%	$113.3M-9.7%	$125.5M+56.7%	$80.1M-33.4%	$120.3M
Investing Cash Flow	-$235.6M-57.0%	-$150.1M+37.3%	-$239.4M-18.9%	-$201.3M-21.7%	-$165.4M-4.4%	-$158.5M+22.2%	-$203.7M-26.1%	-$161.5M
Financing Cash Flow	-$76.9M+25.0%	-$102.5M-5.2%	-$97.4M+14.0%	-$113.2M-25.5%	-$90.2M+30.8%	-$130.4M+13.6%	-$150.9M-68.6%	-$89.5M
Dividends Paid	$18.9M-6.9%	$20.3M+6.8%	$19.0M+11.8%	$17.0M-0.6%	$17.1M-5.0%	$18.0M+5.9%	$17.0M+13.3%	$15.0M
Share Buybacks	$74.2M+3.6%	$71.6M-6.2%	$76.3M+206.4%	$24.9M+0.8%	$24.7M-23.1%	$32.1M+328.0%	$7.5M+10.3%	$6.8M

EHC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

EHC annual financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Margin	N/A	N/A	N/A	12.4%-1.5pp	13.9%-1.9pp	15.8%+2.5pp	13.3%+0.3pp	13.0%-1.8pp	14.8%-1.4pp	16.2%	N/A	N/A	N/A	N/A	N/A
Net Margin	9.5%+1.1pp	8.5%+1.1pp	7.3%+1.1pp	6.2%-4.0pp	10.3%+2.3pp	8.0%+0.2pp	7.8%+1.0pp	6.8%-0.1pp	6.9%+0.1pp	6.8%	N/A	N/A	N/A	N/A	N/A
Return on Equity	23.2%+1.2pp	22.1%+0.7pp	21.4%+0.7pp	20.7%-0.9pp	21.6%+3.7pp	17.9%-8.6pp	26.5%+3.6pp	22.9%-0.6pp	23.5%-10.1pp	33.7%+3.7pp	29.9%-17.0pp	46.9%-47.0pp	93.9%+30.3pp	63.6%-114.8pp	178.4%
Return on Assets	8.0%+1.0pp	7.0%+1.2pp	5.8%+1.0pp	4.8%-1.2pp	6.0%+1.6pp	4.4%-1.5pp	5.9%+0.2pp	5.7%+0.1pp	5.6%+0.3pp	5.3%+1.3pp	4.0%-2.6pp	6.6%-6.2pp	12.8%+5.1pp	7.6%-1.6pp	9.2%
Current Ratio	1.080.0x	1.05-0.2x	1.280.0x	1.250.0x	1.23-0.1x	1.32+0.3x	1.05+0.1x	0.98-0.4x	1.360.0x	1.380.0x	1.40-0.5x	1.880.0x	1.86-0.3x	2.12+0.5x	1.57
Debt-to-Equity	1.00-0.1x	1.14-0.5x	1.63-0.5x	2.09+0.4x	1.70-0.4x	2.05-0.2x	2.24+0.3x	1.94-0.3x	2.21-1.8x	4.05-1.1x	5.13+0.7x	4.420.0x	4.37+0.1x	4.26-6.3x	10.56
FCF Margin	7.4%+0.7pp	6.7%+1.1pp	5.6%+2.3pp	3.2%-1.5pp	4.8%-4.0pp	8.8%+3.0pp	5.7%-6.2pp	11.9%+0.8pp	11.1%-1.7pp	12.7%	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Net Margin	9.6%-2.6pp	12.3%+2.8pp	9.5%+0.9pp	8.6%-1.2pp	9.8%-0.7pp	10.4%+1.8pp	8.6%+0.6pp	8.0%
Return on Equity	5.9%-1.8pp	7.7%+1.7pp	6.0%+0.7pp	5.3%-0.9pp	6.2%-0.8pp	7.0%+1.2pp	5.9%+0.3pp	5.5%
Return on Assets	2.1%-0.6pp	2.7%+0.6pp	2.1%+0.2pp	1.8%-0.2pp	2.1%-0.2pp	2.3%+0.4pp	1.8%+0.2pp	1.7%
Current Ratio	1.190.0x	1.17+0.1x	1.08-0.1x	1.14+0.1x	1.060.0x	1.060.0x	1.050.0x	1.04
Debt-to-Equity	1.000.0x	1.000.0x	1.000.0x	1.010.0x	1.02-0.1x	1.08-0.1x	1.14-0.1x	1.20
FCF Margin	3.9%-5.6pp	9.5%+1.9pp	7.6%+1.9pp	5.7%-2.1pp	7.8%-0.8pp	8.6%+2.9pp	5.7%-3.2pp	8.9%

Not reported in any period shown, so not listed: Gross Margin.

Similar Companies

Univ Health Svc UHS

$10.4B

Fresenius Med Cr FMS

$12.5B

Tenet Healthcare Corp THC

$22.6B

Ensign Group Inc ENSG

$10.5B

Davita Inc DVA

$11.1B

Where Encompass Health Corp Ranks

Frequently Asked Questions

What is Encompass Health Corp's annual revenue?

Encompass Health Corp (EHC) reported $5.9B in total revenue for fiscal year 2025. This represents a 10.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Encompass Health Corp's revenue growing?

Encompass Health Corp (EHC) revenue grew by 10.5% year-over-year, from $5.4B to $5.9B in fiscal year 2025.

Is Encompass Health Corp profitable?

Yes, Encompass Health Corp (EHC) reported a net income of $566.2M in fiscal year 2025, with a net profit margin of 9.5%.

How much debt does Encompass Health Corp have?

As of fiscal year 2025, Encompass Health Corp (EHC) had $72.2M in cash and equivalents against $2.4B in long-term debt.

What is Encompass Health Corp's net profit margin?

Encompass Health Corp (EHC) had a net profit margin of 9.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Encompass Health Corp pay dividends?

Yes, Encompass Health Corp (EHC) paid $0.72 per share in dividends during fiscal year 2025.

What is Encompass Health Corp's return on equity (ROE)?

Encompass Health Corp (EHC) has a return on equity of 23.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Encompass Health Corp's free cash flow?

Encompass Health Corp (EHC) generated $439.2M in free cash flow during fiscal year 2025. This represents a 21.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Encompass Health Corp's operating cash flow?

Encompass Health Corp (EHC) generated $1.2B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Encompass Health Corp's total assets?

Encompass Health Corp (EHC) had $7.1B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Encompass Health Corp's capital expenditures?

Encompass Health Corp (EHC) invested $736.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Encompass Health Corp buy back shares?

Yes, Encompass Health Corp (EHC) spent $158.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Encompass Health Corp have outstanding?

Encompass Health Corp (EHC) had 99M shares outstanding as of fiscal year 2025.

What is Encompass Health Corp's current ratio?

Encompass Health Corp (EHC) had a current ratio of 1.08 as of fiscal year 2025, which is considered adequate.

What is Encompass Health Corp's debt-to-equity ratio?

Encompass Health Corp (EHC) had a debt-to-equity ratio of 1.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Encompass Health Corp's return on assets (ROA)?

Encompass Health Corp (EHC) had a return on assets of 8.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Encompass Health Corp's Piotroski F-Score?

Encompass Health Corp (EHC) has a Piotroski F-Score of 8 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Encompass Health Corp's earnings high quality?

Encompass Health Corp (EHC) has an earnings quality ratio of 2.08x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Encompass Health Corp?

Encompass Health Corp (EHC) scores 32 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.